In addition, inhibition of mTOR by everolimus and a PI3K/mTOR signaling inhibitor which have synergistic effects on each other resulted in a reduction in tumor size in HCC mouse models through an increase in autophagy/mitophagy levels169 (Table 2). The gene discussed is MTOR; the disease is hepatocellular carcinoma.